1223
Last Update Posted: 2025-11-25
Recruiting has ended
All Genders accepted | 4 Years-120 Years |
79 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
Diagnosis and Treatment of Patients With Cystic Fibrosis
This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expand knowledge of the natural history, clinical manifestations (phenotypes) and the genetic variants (genotypes) of cystic fibrosis.
This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expand knowledge of the natural history, clinical manifestations (phenotypes) and the genetic variants (genotypes) of cystic fibrosis.
Eligibility
Relevant conditions:
Cystic Fibrosis
Liver Disease or Abnormalities
Diabetes
Pancreatic Insufficiency (Exocrine and Endocrine)
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
Milica S Chernick, M.D.
milicac@bdg10.niddk.nih.gov
(301) 496-3434
Data sourced from ClinicalTrials.gov